Treatment of Dysplasia in Barrett Esophagus

Barrett esophagus is recognized as a risk factor for the development of dysplasia and adenocarcinoma of the esophagus. Cancer is usually diagnosed at an advanced stage with a 5-year survival rate of 15%. Most of these patients present de novo and are not part of a surveillance program. Endoscopic sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Aranda-Hernandez, Javier, Cirocco, Maria, Marcon, Norman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Gastrointestinal Endoscopy 2014
Materias:
Focused Review Series: Endoscopic and Molecular Imaging of Premalignant GI Lesions, Part II
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928493/
https://www.ncbi.nlm.nih.gov/pubmed/24570884
http://dx.doi.org/10.5946/ce.2014.47.1.55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928493/
https://www.ncbi.nlm.nih.gov/pubmed/24570884
http://dx.doi.org/10.5946/ce.2014.47.1.55

Ejemplares similares